anti-PTH1R mAb (XOMA)

N/A

Report date: 2025/03/18 18:06:07

Base Information

Drug Nameanti-PTH1R mAb (XOMA)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionParathyroid hormone/parathyroid hormone-related peptide receptor inhibitors
TargetsParathyroid hormone/parathyroid hormone-related peptide receptor
Therapy Area/IndicationsHyperparathyroidism, PrimaryHypercalcemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesFrance
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesXoma Corp
China Registration ClassN/A

Develop Information

Active CompaniesXoma CorpAmolyt Pharma SAS
Inactive CompaniesN/A
Active IndicationsHyperparathyroidism, PrimaryHypercalcemia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A